FOCAL CAP FIRST-LINE OBJECTIVE CLINICAL ASSESSMENT OF FOCAL TREATMENT IN LOW-RISK LOCALIZED CANCER OF THE PROSTATE

Welcome to the Brand page for “FOCAL CAP FIRST-LINE OBJECTIVE CLINICAL ASSESSMENT OF FOCAL TREATMENT IN LOW-RISK LOCALIZED CANCER OF THE PROSTATE”, which is offered here for Arranging of colloquiums, conventions and conferences; organization of exhibitions for educational purposes in connection with the field of science; film production for educational and scientific purposes;the mark consists of the wording focal cap with a horizontal line passing through the letters cal in focal. a shaded circle is displayed on the right end of the horizontal line between the words focal and cap. the phrase first-line objective clinical assessment of focal treatment in low-risk localized cancer of the prostate is displayed under focal cap.;pharmaceutical preparations for the diagnosis and treatment of cancers and of prostate disease;color is not claimed as a feature of the mark.;first-line objective clinical assessment of focal treatment in low-risk localized cancer of the prostate;clinical research in the medical and pharmaceutical fields;.

Its status is currently believed to be active. Its class is unavailable. “FOCAL CAP FIRST-LINE OBJECTIVE CLINICAL ASSESSMENT OF FOCAL TREATMENT IN LOW-RISK LOCALIZED CANCER OF THE PROSTATE” is believed to be currently owned by “STEBA FRANCE”.